Nu Skin Enterprises, Inc.
NUS
$12.13
$0.756.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 167.92% | -1,063.13% | -1,805.57% | -276.34% | -311.81% |
| Total Depreciation and Amortization | -14.19% | -9.39% | 0.85% | 5.32% | 1.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -119.52% | -22.23% | 77.02% | 135.81% | 261.50% |
| Change in Net Operating Assets | -1.90% | 69.52% | 65.31% | 83.68% | 87.26% |
| Cash from Operations | -41.52% | -24.45% | -5.81% | 55.70% | 136.93% |
| Capital Expenditure | 34.00% | 27.66% | 28.91% | 4.82% | 19.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.72% | -73.24% | 186.47% | 390.05% | 346.61% |
| Cash from Investing | 477.34% | 218.42% | 71.78% | 70.01% | 69.07% |
| Total Debt Issued | -- | -83.33% | -86.36% | -86.36% | -100.00% |
| Total Debt Repaid | -355.62% | -759.38% | -868.98% | -148.92% | -63.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 58.60% | 58.04% | 84.41% | 90.53% | 69.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 73.32% | 80.48% | 84.63% | 63.54% | 42.08% |
| Other Financing Activities | 119.25% | 76.22% | -- | -- | -- |
| Cash from Financing | -92.14% | -1,083.44% | -1,341.16% | -454.65% | -180.74% |
| Foreign Exchange rate Adjustments | 188.58% | 70.29% | -176.53% | 163.35% | 12.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 453.05% | 49.67% | -698.04% | 90.85% | 91.19% |